1921
Volume 76, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Vascular endothelial growth factor (VEGF) is a potent vascular permeability factor and a mediator of brain edema. To assess the role of vascular endothelial growth factor in eosinophilic meningitis, vascular endothelial growth factor was measured in the cerebrospinal fluid (CSF) and blood of 9 patients with eosinophilic meningitis in a cohort study. VEGF was detected in 8 (90%) of 9 eosinophilic meningitis patients (range, 45–2190 pg/mL) at presentation. The mean VEGF at presentation, 1 week, and 2 weeks after admission was 568 pg/mL, 751 pg/mL, and 1031 pg/mL, respectively. There was an association between VEGF, CSF protein, white cell count, and eosinophil counts. The VEGF fluctuated during the 6-month follow-up period. These results indicate that vascular endothelial growth factor may be associated with blood-brain barrier disruption in patients with eosinophilic meningitis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.76.592
2007-03-01
2017-09-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/76/3/0760592.html?itemId=/content/journals/10.4269/ajtmh.2007.76.592&mimeType=html&fmt=ahah

References

  1. Beaver PC, Rosen L, 1945. Memorandum on the first report of Angiostrongylus in man by Nomura and Lin. Am J Trop Med Hyg 13 : 589–590.
  2. Rosen L, Chappell R, Laqueur GL, 1962. Eosinophilic meningoencephalitis caused by a metastrongylid lung worm of rats. JAMA 179 : 620–624.
  3. Punyagupta S, Juttijudata P, Bunnag T, 1975. Eosinophilic meningitis in Thailand: clinical studies of 484 typical cases probably caused by Angiostrongylus. Am J Trop Med Hyg 24 : 921–931.
  4. Yii CY, 1976. Clinical observations on eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis on Taiwan. Am J Trop Med Hyg 25 : 233–249.
  5. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN, 1988. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45 : 954–958.
  6. Lee JD, Tsai LY, Chen CH, Wang JJ, Hsiao JK, Yen CM, 2006. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop 97 : 204–211.
  7. van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van Diemen-Steenvoorde RA, van der Vlist GJ, Rupert SW, Schmutzhard E, Gunsilius E, Gastl G, Hoepelman AI, Kimpen JL, Geelen SP, 2001. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis 183 : 149–153.
  8. Connolly DT, 1991. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 47 : 219–223.
  9. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lookeren Campagne M, Ferrara N, 1999. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104 : 1613–1620.
  10. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Geelen SP, Kimpen JL, Schoeman JF, 2004. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J 23 : 608–613.
  11. Tsai HC, Lee SS, Huang CK, Yen CM, Chen ER, Liu YC, 2004. Outbreak of eosinophilic meningitis associated with drinking raw vegetable juice in southern Taiwan. Am J Trop Med Hyg 71 : 222–226.
  12. Tsai HC, Liu YC, Kunin CM, Lee SS, Chen YS, Lin HH, Tsai TH, Lin WR, Huang CK, Yen MY, Yen CM, 2001. Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am J Med 111 : 109–114.
  13. Tsai HC, Liu YC, Kunin CM, Lai PH, Lee SS, Chen YS, Wann SR, Lin WR, Huang CK, Ger LP, Lin HH, Yen MY, 2003. Eosinophilic meningitis caused by Angiostrongylus cantonensis associated with eating raw snails: correlation of brain magnetic resonance Imaging scans with clinical findings. Am J Trop Med Hyg 68 : 281–285.
  14. Chye SM, Chang JH, Yen CM, 2000. Immunodiagnosis of human eosinophilic meningitis using an antigen of Angiostrongylus cantonensis L5 with molecular weight 204KD. Acta Trop 75 : 9–17.
  15. Bisser S, Lejon V, Preux PM, Bouteille B, Stanghellini A, Jauberteau MO, Buscher P, Dumas M, 2002. Blood–cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci 193 : 127–135.
  16. Quagliarello V, Scheld WM, 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 327 : 864–872.
  17. Dorta-Contreras AJ, Reiber H, 1998. Intrathecal synthesis of immunoglobulins in eosinophilic meningoencephalitis due to Angiostrongylus cantonensis. Clin Diagn Lab Immunol 5 : 452–455.
  18. Reiber H, 1994. Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood–CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122 : 189–203.
  19. Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, Vogelbaum M, Kinter M, Rasmussen P, Mayberg MR, Janigro D, 2003. Serum transthyretin monomer as a possible marker of blood–to–CSF barrier disruption. J Neurosci 23 : 1949–1955.
  20. Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, Merrill MJ, 1999. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 8 : 613–627.
  21. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, Perez CM, 1997. Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA 278 : 925–931.
  22. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH, 1996. Mechanism of dexamethasone suppression of brain tumor–associated vascular permeability in rats: involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest 98 : 1400–1408.
  23. Chotmongkol V, Sawanyawisuth K, Thavornpitak Y, 2000. Corticosteroid treatment of eosinophilic meningitis. Clin Infect Dis 31 : 660–662.
  24. Sawanyawisuth K, Limpawattana P, Busaracome P, Ninpaitoon B, Chotmongkol V, Intapan PM, Tanawirattananit S, 2004. 1-week course of corticosteroids in the treatment of eosinophilic meningitis. Am J Med 117 : 802–803.
  25. Kaal EC, Vecht CJ, 2004. The management of brain edema in brain tumors. Curr Opin Oncol 16 : 593–600.
  26. Kroll RA, Neuwelt EA, 1998. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42 : 1083–1099.
  27. Berk BC, Corson MA, Peterson TE, Tseng H, 1995. Protein kinases as mediators of fluid shear stress stimulated signal trans-duction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech 28 : 1439–1450.
  28. Dascalu A, Oron Y, Nevo Z, Korenstein R, 1995. Hyperosmotic modulation of the cytosolic calcium concentration in a rat osteoplast-like cell line. J Physiol 486 : 97–104.
  29. Leib SL, Tauber MG, 1999. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 13 : 527–548.
  30. Stockhammer G, Poewe W, Burgstaller S, Deisenhammer F, Muigg A, Kiechl S, Schmutzhard E, Maier H, Felber S, Schumacher P, Gunsilius E, Gastl G, 2000. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology 54 : 1670–1676.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.76.592
Loading
/content/journals/10.4269/ajtmh.2007.76.592
Loading

Data & Media loading...

  • Received : 29 Jul 2006
  • Accepted : 05 Dec 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error